Wealth Architects, LLC - ARIDIS PHARMACEUTICALS INC ownership

ARIDIS PHARMACEUTICALS INC's ticker is ARDS and the CUSIP is 040334104. A total of 18 filers reported holding ARIDIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Wealth Architects, LLC ownership history of ARIDIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,437
-53.6%
14,0770.0%0.00%
-100.0%
Q2 2023$3,096
-30.0%
14,0770.0%0.00%0.0%
Q1 2023$4,422
-73.4%
14,0770.0%0.00%
-66.7%
Q4 2022$16,611
+27.8%
14,0770.0%0.00%0.0%
Q3 2022$13,000
-13.3%
14,0770.0%0.00%0.0%
Q2 2022$15,000
-40.0%
14,0770.0%0.00%
-25.0%
Q1 2022$25,000
-24.2%
14,0770.0%0.00%
-33.3%
Q4 2021$33,000
-36.5%
14,0770.0%0.01%
-40.0%
Q3 2021$52,00014,0770.01%
Other shareholders
ARIDIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 446,588$1,041,0001.39%
PERRITT CAPITAL MANAGEMENT INC 24,000$56,0000.03%
Wealth Architects, LLC 14,077$33,0000.01%
Virtu Financial LLC 12,200$28,0000.00%
Focused Wealth Management, Inc 100$00.00%
JANE STREET GROUP, LLC 39,680$92,0000.00%
OSAIC HOLDINGS, INC. 9,000$21,0000.00%
WELLS FARGO & COMPANY/MN 1,294$3,0000.00%
NORTHERN TRUST CORP 16,572$39,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ARIDIS PHARMACEUTICALS INC shareholders